InvestorsHub Logo
icon url

Batermere

05/20/17 8:12 AM

#105694 RE: Amatuer17 #105691

Those are all valid concerns, Amatuer. AVXL is by no means a slam dunk. Very few Biotechs are, especially those attempting to cure the CNS maladies that AVXL is involved with. The one that baffles me the most is why the long awaited 15 month data has not been released. What game is Missling playing here? RELEASE THE DAMN DATA, good or bad. The silence is deafening.
icon url

Djia

05/20/17 11:04 AM

#105705 RE: Amatuer17 #105691

regarding - results inconsistent and non-conclusive

remember that that was only a phase II trial not meant to prove efficacy.,....